Internal Medicine Alert
RSSArticles
-
Changing Gut Microbiota to Prevent Type 2 Diabetes
The long-term consumption of a healthy diet, such as the Mediterranean diet or low-fat/high complex carbohydrate diets, may exert a protective effect on the development of type 2 diabetes by changing the gut microbiota.
-
Statins Associated with Lower Parkinson’s Risk in Diabetics
In approximately 50,000 individuals with Parkinson’s disease and diabetes, identified from a National Health Insurance database in Taiwan, statin use was dose-dependently associated with lower risk of Parkinson’s disease.
-
Why Do the Beats Keep Changing?
What clinical situation commonly is associated with arrhythmias such as the one shown in this figure?
-
Adalimumab-atto Injection (Amjevita)
Adalimumab-atto provides an alternative to adalimumab for multiple chronic inflammatory conditions.
-
Optimal Blood Pressure in Patients Presenting with Aortic Stenosis
A post-hoc analysis of patients suffering from mild to moderate aortic stenosis in a study of low-density lipoprotein cholesterol lowering showed that the optimal blood pressure for the best survival was 130-139/70-90 mmHg.
-
What Should You Tell Your Patients About Sleep Apnea, CPAP, and Heart Disease?
In this large, multicenter, randomized, controlled trial, continuous positive airway pressure did not reduce incident cardiovascular events compared with usual care, but did reduce snoring and daytime sleepiness and improved health-related quality of life and mood.
-
Clinical Briefs
In this section: improving CPAP adherence; drug therapy for type 2 diabetes; and correcting inhaler techniques.
-
Aspirin and Omeprazole Delayed-release Tablets (Yosprala)
The combination is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of aspirin-associated gastric ulcers.
-
Headaches in the Elderly: A Non-specific Marker for Stroke Risk
Non-migrainous headaches, for which there are many causes, appear to be a risk factor for stroke in an elderly population, but the mechanism is uncertain.
-
The Growing Threat of Pyelonephritis Caused by Antibiotic-resistant Escherichia coli
In patients with acute pyelonephritis due to Escherichia coli presenting to one of 10 EDs, the prevalence of fluoroquinolone resistance ranged from 6.3% to 19.9%, and the prevalence of extended-spectrum beta-lactamase production was 2.6% to 12.2%.